IP Library › Assignment 023364/0467
Patent Assignment
Reel/Frame 023364/0467

Assignment of Assignor's Interest

Recorded: 2009-10-13 Pages: 4
Assignors
LEADBETTER, MICHAEL R.
Executed: 2000-10-03
LINSELL, MARTIN S.
Executed: 2000-10-03
Assignee
ADVANCED MEDICINE, INC.
901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (5)
Glycopeptide Phosphonate Derivatives
Patent: 6,635,618 →
Application: 09/847,042 →
Publication: US 2002/0022590
Glycopeptide Phosphonate Derivatives
Patent: 6,872,701 →
Application: 10/436,341 →
Publication: US 2003/0207797
Glycopeptide Phosphonate Derivatives
Patent: 7,008,923 →
Application: 11/037,934 →
Publication: US 2005/0164916
Glycopetide Phosphonate Derivatives
Patent: 7,208,471 →
Application: 11/265,570 →
Publication: US 2006/0063706
Glycopeptide Phosphonate Derivatives
Patent: 7,351,691 →
Application: 11/584,908 →
Publication: US 2007/0049519
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 6, 2001
From: LEADBETTER, MICHAEL R.; LINSELL, MARTIN S.
To: ADVANCED MEDICINE, INC.
Reel/Frame 012049/0333 →
Merger Jun 14, 2002
From: ADVANCED MEDICINE, INC.
To: THERAVANCE, INC.
Reel/Frame 013003/0075 →
Assignment of Assignor's Interest Oct 13, 2009
From: LEADBETTER, MICHAEL R.; LINSELL, MARTIN S.
To: ADVANCED MEDICINE, INC.
Reel/Frame 023364/0435 →
Merger Oct 13, 2009
From: ADVANCED MEDICINE, INC.
To: THERAVANCE, INC.
Reel/Frame 023364/0442 →
Assignment of Assignor's Interest Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033181/0646 →
Assignment of Assignor's Interest Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →